Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram

被引:9
|
作者
Shi, Shuguang [1 ]
Miao, Zhongchang [1 ]
Zhou, Ying [1 ]
Xu, Chunling [1 ]
Zhang, Xue [1 ]
机构
[1] Nanjing Med Univ, Dept Radiol, Kangda Coll, Affiliated Hosp 1,Peoples Hosp Lianyungang 1, Jiangsu, Peoples R China
来源
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY | 2022年 / 28卷 / 05期
关键词
LYMPH-NODE; PHENOTYPE; PROGNOSIS;
D O I
10.5152/dir.2022.211034
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE Radiomics can be used to determine the prognosis of gastric cancer (GC). The objective of this study was to predict the disease-free survival (DFS) after GC surgery based on computed tomography-enhanced images combined with clinical features. METHODS Clinical, imaging, and pathological data of patients who underwent gastric adenocarcinoma resection from June 2015 to May 2019 were retrospectively analyzed. The primary outcome was DFS. Radiomics features were selected using Least Absolute Shrinkage and Selection Operator algorithm and converted into the Rad-score. A nomogram was constructed based on the Radscore and other clinical factors. The Rad-score and nomogram were validated in the training and validation groups. RESULTS Totally, 179 patients were randomly divided into the training (n = 124) and validation (n = 55) groups. In the training group, validation group, and overall population, the Rad-score could be divided into categories indicating low, moderate, and high risk of recurrence, metastasis, or death; all risk categories showed a significant difference between the training, validation, and overall population groups (all P <.001). Positive lymph nodes (hazard ratio (HR) = 3.07, 95% CI: 1.52-6.23, P =.002), cancer antigen-125 (HR = 3.24, 95% CI: 1.54-6.80, P =.002), and the Radscore (HR = 0.73, 95% CI: 0.61-0.87, P <.001) were independently associated with DFS. These 3 variables were used to construct a nomogram. In the training group, the areas under the curve at 3 years were 0.758 and 0.776 for the Rad-score and the nomogram, respectively, while they were both 1.000 in the validation group. The net benefit rate was analyzed using a decision curve in the training and validation groups, and the nomogram was superior to the single Rad-score. CONCLUSION Rad-score is an independent factor for DFS after gastrectomy for GC. The nomogram established in this study could be an effective tool for the clinical prediction of DFS after gastrectomy.
引用
收藏
页码:441 / +
页数:10
相关论文
共 50 条
  • [41] Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma
    Zhu, Zhenzhen
    Wang, Weiqing
    Zha, Yang
    Wang, Xiaowei
    Aodeng, Surita
    Wang, Lei
    Liu, Yuzhuo
    Lv, Wei
    BMC CANCER, 2024, 24 (01)
  • [42] Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma
    Zhenzhen Zhu
    Weiqing Wang
    Yang Zha
    Xiaowei Wang
    Surita Aodeng
    Lei Wang
    Yuzhuo Liu
    Wei Lv
    BMC Cancer, 24
  • [43] Development and Validation Nomogram for Predicting the Survival of Patients with Thrombocytopenia in Intensive Care Units
    Jiang, Zhen-Hong
    Zhang, Guo-Hu
    Xia, Jin-Ming
    Lv, Shi-Jin
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2023, 16 : 1287 - 1295
  • [44] Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms
    Xie, Si
    Li, Lei
    Wang, Xiaotong
    Li, Lequn
    MEDICINE, 2021, 100 (02) : E24223
  • [45] Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy
    Lai, Jianguo
    Wang, Hongli
    Peng, Jingwen
    Chen, Peixian
    Pan, Zihao
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 2347 - 2356
  • [46] Development and validation of a 18F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study
    Liu, Huiling
    Cui, Yongbin
    Chang, Cheng
    Zhou, Zichun
    Zhang, Yalin
    Ma, Changsheng
    Yin, Yong
    Wang, Ruozheng
    BMC CANCER, 2024, 24 (01)
  • [47] Development and validation of a preoperative MRI-based radiomics nomogram to predict progression-free survival in patients with clival chordomas
    Zhai, Yixuan
    Bai, Jiwei
    Xue, Yake
    Li, Mingxuan
    Mao, Wenbin
    Zhang, Xuezhi
    Zhang, Yazhuo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study
    Xie, Liangyun
    Zhang, Yafei
    Niu, Xiedong
    Jiang, Xiaomei
    Kang, Yuan
    Diao, Xinyue
    Fang, Jinhai
    Yu, Yilin
    Yao, Jun
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [49] A novel inflammation-related prognostic biomarker for predicting the disease-free survival of patients with colorectal cancer
    Cai, Xiaoling
    Chen, Fa
    Liang, Lisheng
    Jiang, Weizhong
    Liu, Xing
    Wang, Dong
    Wu, Yunli
    Chen, Jinyan
    Guan, Guoxian
    Peng, Xian-e
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [50] Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer
    Zhang, Jun
    Piao, Hai-Yan
    Wang, Yue
    Lou, Mei-Yue
    Guo, Shuai
    Zhao, Yan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (44) : 6929 - 6944